Genetic analysis of connective tissue growth factor as an effector of transforming growth factor β signaling and cardiac remodeling

Molecular and Cellular Biology

Volumn 35, Issue 12, 2015, Pages 2154-2164

  Accornero, Federica ^a   van Berlo, Jop H ^a   Correll, Robert N ^a   Elrod, John W ^b   Sargent, Michelle A ^a   York, Allen ^a   Rabinowitz, Joseph E ^b   Leask, Andrew ^c   Molkentin, Jeffery D ^a,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WESTERN UNIVERSITY   (Canada)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; HYDROXYPROLINE; MUTANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE STRESS; ADULT; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEART MUSCLE FIBROSIS; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; FIBROSIS; GENE EXPRESSION; GENE TARGETING; GENETICS; HEART MUSCLE; METABOLISM; PATHOLOGY; UPREGULATION;

MUS; MUS MUSCULUS;

ANIMALS; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; FIBROSIS; GENE DELETION; GENE EXPRESSION; GENE TARGETING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84929441380     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00199-15     Document Type: Article

References (51)

1. Kehat I, Molkentin JD. 2010. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122: 2727-2735. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.942268.
2. Sabbah HN, Sharov VG, Lesch M, Goldstein S. 1995. Progression of heart failure: a role for interstitial fibrosis. Mol Cell Biochem 147:29-34. http://dx.doi.org/10.1007/BF00944780.
3. Manabe I, Shindo T, Nagai R. 2002. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91:1103-1113. http://dx.doi.org/10.1161/01.RES.0000046452.67724.B8.
4. Leask A. 2010. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 106:1675-1680. http://dx.doi.org/10.1161/CIRCRESAHA.110.217737.
5. Leask A, Abraham DJ. 2004. TGF-beta signaling and the fibrotic response. FASEB J 18:816-827. http://dx.doi.org/10.1096/fj.03-1273rev.
6. Brand T, Schneider MD. 1995. The TGF beta superfamily in myocardium: ligands, receptors, transduction, and function. J Mol Cell Cardiol 27:5-18. http://dx.doi.org/10.1016/S0022-2828(08)80003-X.
7. Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA. 2011. Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. J Clin Invest 121:2301-2312. http://dx.doi.org/10.1172/JCI44824.
8. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T. 2002. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressureoverloaded rats. Circulation 106:130-135. http://dx.doi.org/10.1161/01.CIR.0000020689.12472.E0.
9. Frantz S, Hu K, Adamek A, Wolf J, Sallam A, Maier SK, Lonning S, Ling H, Ertl G, Bauersachs J. 2008. Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol 103:485-492. http://dx.doi.org/10.1007/s00395-008-0739-7.
10. Shi-wen X, Stanton LA, Kennedy L, Pala D, Chen Y, Howat SL, Renzoni EA, Carter DE, Bou-Gharios G, Stratton RJ, Pearson JD, Beier F, Lyons KM, Black CM, Abraham DJ, Leask A. 2006. CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem 281:10715-10726. http://dx.doi.org/10.1074/jbc.M511343200.
11. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K. 1999. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 181:153-159. http://dx.doi.org/10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K.
12. Leask A, Abraham DJ. 2006. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119:4803-4810. http://dx.doi.org/10.1242/jcs.03270.
13. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM. 2003. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779-2791. http://dx.doi.org/10.1242/dev.00505.
14. Ahmed MS, Oie E, Vinge LE, Yndestad A, Oystein Andersen G, Andersson Y, Attramadal T, Attramadal H. 2004. Connective tissue growth factor-a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol 36:393-404. http://dx.doi.org/10.1016/j.yjmcc.2003.12.004.
15. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. 2000. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 32:1805-1819. http://dx.doi.org/10.1006/jmcc.2000.1215.
16. Chuva de Sousa Lopes SM, Feijen A, Korving J, Korchynskyi O, Larsson J, Karlsson S, ten Dijke P, Lyons KM, Goldschmeding R, Doevendans P, Mummery CL. 2004. Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Dev Dyn 231:542-550. http://dx.doi.org/10.1002/dvdy.20162.
17. Behnes M, Brueckmann M, Lang S, Weiss C, Ahmad-Nejad P, Neumaier M, Borggrefe M, Hoffmann U. 2014. Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure. Clin Res Cardiol 103:107-116. http://dx.doi.org/10.1007/s00392-013-0626-6.
18. Koshman YE, Patel N, Chu M, Iyengar R, Kim T, Ersahin C, Lewis W, Heroux A, Samarel AM. 2013. Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure. J Card Fail 19:283-294. http://dx.doi.org/10.1016/j.cardfail.2013.01.013.
19. Sanbe A, Gulick J, Hanks MC, Liang Q, Osinska H, Robbins J. 2003. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 92:609-616. http://dx.doi.org/10.1161/01.RES.0000065442.64694.9F.
20. Liu S, Shi-wen X, Abraham DJ, Leask A. 2011. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum 63:239-246. http://dx.doi.org/10.1002/art.30074.
21. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. 2008. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 16:1073-1080. http://dx.doi.org/10.1038/mt.2008.76.
22. Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD. 2004. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94:110-118. http://dx.doi.org/10.1161/01.RES.0000109415.17511.18.
23. Nakayama H, Bodi I, Correll RN, Chen X, Lorenz J, Houser SR, Robbins J, Schwartz A, Molkentin JD. 2009. Alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest 119:3787-3796. http://dx.doi.org/10.1172/JCI39724.
24. Accornero F, van Berlo JH, Benard MJ, Lorenz JN, Carmeliet P, Molkentin JD. 2011. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 109:272-280. http://dx.doi.org/10.1161/CIRCRESAHA.111.240820.
25. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. 1995. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 92:2572-2576. http://dx.doi.org/10.1073/pnas.92.7.2572.
26. Tsoutsman T, Wang X, Garchow K, Riser B, Twigg S, Semsarian C. 2013. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure. J Mol Cell Cardiol 62:164-178. http://dx.doi.org/10.1016/j.yjmcc.2013.05.019.
27. Gressner OA, Lahme B, Siluschek M, Rehbein K, Weiskirchen R, Gressner AM. 2009. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes-but without modulating bone morphogenetic protein 7 signaling. Hepatology 49:2021-2030. http://dx.doi.org/10.1002/hep.22850.
28. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. 2002. Connectivetissue growth factor (CTGF) modulates cell signalling by BMP and TGFbeta. Nat Cell Biol 4:599-604. http://dx.doi.org/10.1038/ncb826.
29. Parada C, Li J, Iwata J, Suzuki A, Chai Y. 2013. CTGF mediates Smaddependent transforming growth factor beta signaling to regulate mesenchymal cell proliferation during palate development. Mol Cell Biol 33: 3482-3493. http://dx.doi.org/10.1128/MCB.00615-13.
30. Perbal B. 2004. CCN proteins: multifunctional signalling regulators. Lancet 363:62-64. http://dx.doi.org/10.1016/S0140-6736(03)15172-0.
31. Shi-Wen X, Leask A, Abraham D. 2008. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 19:133-144. http://dx.doi.org/10.1016/j.cytogfr.2008.01.002.
32. Liu S, Herault Y, Pavlovic G, Leask A. 2014. Skin progenitor cells contribute to bleomycin-induced skin fibrosis. Arthritis Rheumatol 66: 707-713. http://dx.doi.org/10.1002/art.38276.
33. Biernacka A, Dobaczewski M, Frangogiannis NG. 2011. TGF-beta sig-naling in fibrosis. Growth Factors 29:196-202. http://dx.doi.org/10.3109/08977194.2011.595714.
34. Grotendorst GR, Okochi H, Hayashi N. 1996. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7:469-480.
35. Ahmed MS, Gravning J, Martinov VN, von Lueder TG, Edvardsen T, Czibik G, Moe IT, Vinge LE, Oie E, Valen G, Attramadal H. 2011. Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 300: H1291-H1302. http://dx.doi.org/10.1152/ajpheart.00604.2010.
36. Panek AN, Posch MG, Alenina N, Ghadge SK, Erdmann B, Popova E, Perrot A, Geier C, Dietz R, Morano I, Bader M, Ozcelik C. 2009. Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One 4:e6743. http://dx.doi.org/10.1371/journal.pone.0006743.
37. Gravning J, Orn S, Kaasboll OJ, Martinov VN, Manhenke C, Dickstein K, Edvardsen T, Attramadal H, Ahmed MS. 2012. Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction. PLoS One 7:e52120. http://dx.doi.org/10.1371/journal.pone.0052120.
38. Gravning J, Ahmed MS, von Lueder TG, Edvardsen T, Attramadal H. 2013. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. Int J Cardiol 168:2049-2056. http://dx.doi.org/10.1016/j.ijcard.2013.01.165.
39. Wang X, McLennan SV, Allen TJ, Tsoutsman T, Semsarian C, Twigg SM. 2009. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor. Am J Physiol Cell Physiol 297:C1490-C1500. http://dx.doi.org/10.1152/ajpcell.00049.2009.
40. Yoon PO, Lee MA, Cha H, Jeong MH, Kim J, Jang SP, Choi BY, Jeong D, Yang DK, Hajjar RJ, Park WJ. 2010. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 49:294-303. http://dx.doi.org/10.1016/j.yjmcc.2010.04.010.
41. Jun JI, Lau LF. 2011. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 10:945-963. http://dx.doi.org/10.1038/nrd3599.
42. Szabo Z, Magga J, Alakoski T, Ulvila J, Piuhola J, Vainio L, Kivirikko KI, Vuolteenaho O, Ruskoaho H, Lipson KE, Signore P, Kerkela R. 2014. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Hypertension 63:1235-1240. http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03279.
43. Garrett Q, Khaw PT, Blalock TD, Schultz GS, Grotendorst GR, Daniels JT. 2004. Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci 45:1109-1116. http://dx.doi.org/10.1167/iovs.03-0660.
44. Gao R, Brigstock DR. 2004. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279:8848-8855. http://dx.doi.org/10.1074/jbc.M313204200.
45. Babic AM, Chen CC, Lau LF. 1999. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19:2958-2966.
46. Fuchshofer R, Ullmann S, Zeilbeck LF, Baumann M, Junglas B, Tamm ER. 2011. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury. Histochem Cell Biol 136:301-319. http://dx.doi.org/10.1007/s00418-011-0844-9.
47. Hayata N, Fujio Y, Yamamoto Y, Iwakura T, Obana M, Takai M, Mohri T, Nonen S, Maeda M, Azuma J. 2008. Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem Biophys Res Commun 370:274-278. http://dx.doi.org/10.1016/j.bbrc.2008.03.100.
48. Vranka J, Mokashi A, Keene DR, Tufa S, Corson G, Sussman M, Horton WA, Maddox K, Sakai L, Bachinger HP. 2001. Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia. Matrix Biol 20:439-450. http://dx.doi.org/10.1016/S0945-053X(01)00148-2.
49. Lynch JM, Maillet M, Vanhoutte D, Schloemer A, Sargent MA, Blair NS, Lynch KA, Okada T, Aronow BJ, Osinska H, Prywes R, Lorenz JN, Mori K, Lawler J, Robbins J, Molkentin JD. 2012. A thrombospondindependent pathway for a protective ER stress response. Cell 149:1257-1268. http://dx.doi.org/10.1016/j.cell.2012.03.050.
50. Todorovic V, Rifkin DB. 2012. LTBPs, more than just an escort service. J Cell Biochem 113:410-418. http://dx.doi.org/10.1002/jcb.23385.
51. Perera M, Tsang CS, Distel RJ, Lacy JN, Ohno-Machado L, Ricchiuti V, Samaranayake LP, Smejkal GB, Smith MG, Trachtenberg AJ, Kuo WP. 2010. TGF-beta1 interactome: metastasis and beyond. Cancer Genomics Proteomics 7:217-229.